The CDC recently issued an advisory about a bacteria called shigella due to a nationwide increase in infections resulting from drug-resistant strains. The easily transmissible bacteria causes an infection called shigellosis that is uncomfortable and unpleasant but rarely life-threatening — the main symptom is inflammatory diarrhea.
CMS is cracking down on hospital-acquired infections, starting with MRSA and C. difficile.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
The new scopes are coming primarily from smaller companies looking to challenge a handful of dominant device makers.
The collaborative brings together more acronyms than an army battle map, international drug research expertise and as much as $350 million in funding to tackle this looming crisis.
Scope devices that are difficult to clean have been called out in certain cases for causing antibiotic-resistant infections in the past. Olympus, a Japan-based device maker, failed to report infection investigations to the FDA or American hospitals, and they are now being called out.
Surfers might have a unique contribution when it comes to addressing the threat of drug-resistant bacteria.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.